Belgium’s Bioqube earmarking some of planned €100M fund for ‘de-risking’ projects

With first €60M close, Bioqube seeks mix of traditional early-stage deals and asset-centric investments

Four years after its launch as the manager of companies in J&J’s Belgian incubator, Bioqube Ventures has raised €60 million toward its first independent venture fund earmarked for European start-ups operating in its sweet spots -- with the pharma serving as one

Read the full 422 word article

How to gain access

Continue reading with a
two-week free trial.